BSE filing, BSE: 542678. Summary written from the filing by ALFA Finder's alert engine.
Cian Healthcare Ltd: key numbers
- Share price
- ₹32.20
- Market cap
- ₹80.50 Cr
- Revenue (annual)
- ₹28.30 Cr
- Net profit (annual)
- ₹-23.29 Cr
- Promoter holding
- 95.00%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cian Healthcare Ltd
All →Cian Healthcare Merger & Restructuring
Cian Healthcare disposed of its Dr. Smiths Biotech subsidiary under an NCLT-approved resolution plan. Its equity was cancelled with nil consideration receivable.
Cian Healthcare Insolvency Petition
Cian Healthcare's subsidiary Dr. Smiths Biotech ceased to be a subsidiary after NCLT approved Ananta Medicare's resolution plan. Equity was extinguished with no consideration received.
Cian Healthcare Other Announcement
Cian Healthcare filed its quarterly shareholding pattern. The company disclosed it is working to restore public shareholding levels following an NCLT-approved resolution plan.
Cian Healthcare Management Change
Cian Healthcare Limited has appointed M/s. Rasool Singhal & Co. as the new Statutory Auditor for a term of 60 months.
Cian Healthcare Annual General Meeting
Cian Healthcare Ltd held its 23rd AGM on September 29, 2026, approving financial statements, director re-appointment, auditor appointment, and the 2026 Employee Stock Option Scheme.
Cian Healthcare Annual Report
Cian Healthcare Limited has filed its Annual Report for the financial year ended March 31, 2026, and the Notice of its 23rd Annual General Meeting.
Other other announcement announcements
All →Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.
Banaras Beads Other Announcement
Banaras Beads Ltd filed its half-year related-party transaction disclosure under Listing Regulation 23(9). The filing reports routine remuneration and sitting fees to promoters and directors.
Gita Renewable Energy Other Announcement
Gita Renewable Energy intimated a change in its CIN after altering its Objects Clause. The change followed a Special Resolution at its 16th AGM.
Indian Toners & Developers Other Announcement
Indian Toners & Developers has intimated that NSE approved listing of its 5.19 crore equity shares (₹2 face value) on the NSE Mainboard effective October 30, 2026. This is an additional-exchange admission of already-issued BSE-listed shares.